» Articles » PMID: 31458811

Domain-Specific Association of a Phenanthrene-Pyrene-Based Synthetic Fluorescent Probe with Bovine Serum Albumin: Spectroscopic and Molecular Docking Analysis

Overview
Journal ACS Omega
Specialty Chemistry
Date 2019 Aug 29
PMID 31458811
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

In this report, the interaction between a phenanthrene-pyrene-based fluorescent probe (PPI) and bovine serum albumin (BSA), a transport protein, has been explored by steady-state emission spectroscopy, fluorescence anisotropy, far-ultraviolet circular dichroism (CD), time-resolved spectral measurements, and molecular docking simulation study. The blue shift along with emission enhancement indicates the interaction between PPI and BSA. The binding of the probe causes quenching of BSA fluorescence through both static and dynamic quenching mechanisms, revealing a 1:1 interaction, as delineated from Benesi-Hildebrand plot, with a binding constant of ∼10 M, which is in excellent agreement with the binding constant extracted from fluorescence anisotropy measurements. The thermodynamic parameters, Δ°, Δ°, and Δ°, as determined from van't Hoff relationship indicate the predominance of van der Waals/extensive hydrogen-bonding interactions for the binding phenomenon. The molecular docking and site-selective binding studies reveal the predominant binding of PPI in subdomain IIA of BSA. From the fluorescence resonance energy transfer study, the average distance between tryptophan 213 of the BSA donor and the PPI acceptor is found to be 3.04 nm. CD study demonstrates the reduction of α-helical content of BSA protein on binding with PPI, clearly indicating the change of conformation of BSA.

Citing Articles

Antibacterial and cytotoxicity studies of pyrrolo-based organic scaffolds and their binding interaction with bovine serum albumin.

Das R, Dash P, Bishoyi A, Mohanty P, Mishra L, Prusty L Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(11):8725-8743.

PMID: 38829386 DOI: 10.1007/s00210-024-03187-4.


Synthesis, Structural Investigations, DNA/BSA Interactions, Molecular Docking Studies, and Anticancer Activity of a New 1,4-Disubstituted 1,2,3-Triazole Derivative.

Gokturk T, Sakalli Cetin E, Hokelek T, Pekel H, Sensoy O, Aksu E ACS Omega. 2023; 8(35):31839-31856.

PMID: 37692230 PMC: 10483525. DOI: 10.1021/acsomega.3c03355.


Integrated Approach to Interaction Studies of Pyrene Derivatives with Bovine Serum Albumin: Insights from Theory and Experiment.

Sengottiyan S, Malakar K, Kathiravan A, Velusamy M, Mikolajczyk A, Puzyn T J Phys Chem B. 2022; 126(21):3831-3843.

PMID: 35583491 PMC: 9169062. DOI: 10.1021/acs.jpcb.2c00778.


Pyrene-based metal-organic framework NU-1000 photocatalysed atom-transfer radical addition for iodoperfluoroalkylation and ()-selective perfluoroalkylation of olefins by visible-light irradiation.

Zhang T, Wang P, Gao Z, An Y, He C, Duan C RSC Adv. 2022; 8(57):32610-32620.

PMID: 35547715 PMC: 9086246. DOI: 10.1039/c8ra06181e.


Fluorescence Microscopy-An Outline of Hardware, Biological Handling, and Fluorophore Considerations.

Hickey S, Ung B, Bader C, Brooks R, Lazniewska J, Johnson I Cells. 2022; 11(1).

PMID: 35011596 PMC: 8750338. DOI: 10.3390/cells11010035.


References
1.
Sudlow G, Birkett D, Wade D . Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol. 1976; 12(6):1052-61. View

2.
Revault , Quiquampoix , BARON . Conformational Changes of Bovine Serum Albumin Induced by Adsorption on Different Clay Surfaces: FTIR Analysis. J Colloid Interface Sci. 2000; 221(2):273-283. DOI: 10.1006/jcis.1999.6576. View

3.
Baroni S, Mattu M, Vannini A, Cipollone R, Aime S, Ascenzi P . Effect of ibuprofen and warfarin on the allosteric properties of haem-human serum albumin. A spectroscopic study. Eur J Biochem. 2001; 268(23):6214-20. DOI: 10.1046/j.0014-2956.2001.02569.x. View

4.
Cohen B, McAnaney T, Park E, Jan Y, Boxer S, Jan L . Probing protein electrostatics with a synthetic fluorescent amino acid. Science. 2002; 296(5573):1700-3. DOI: 10.1126/science.1069346. View

5.
Sudlow G, Birkett D, Wade D . The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol. 1975; 11(6):824-32. View